DMARDs

Safety Guidelines Issued for Use of RA Drugs During Pregnancy and Lactation

Safety Guidelines Issued for Use of RA Drugs During Pregnancy and Lactation

By

Although a majority of women with rheumatoid arthritis were previously though to achieve remission during pregnancy, recent studies indicate remission occurs in only 20% to 40% of cases.

Second Biologic Effective in RA After Initial Treatment Failure

Second Biologic Effective in RA After Initial Treatment Failure

By

DMARDs alone or with methotrexate and tofacitinib plus methotrexate improved disease activity and remission rates in patients with RA who have not responded to previous biologic therapy.

Sign Up for Free e-Newsletters